NEW YORK BIOTECHNOLOGY ASSOCIATION INC (EIN 113026494) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1990

Legal Domicile

Principal Officer

JENNIFER A HAWKS BLAND

Phone

2124332623

Tax Period

2025-01-01 to 2025-12-31

NEW YORK BIOTECHNOLOGY ASSOCIATION INC, founded in 1990, is a community nonprofit in the Community Improvement sector that reported $1.7M in total revenue in fiscal year 2025. Revenue surged 23% from the prior year, signaling strong growth momentum. Expenses of $1.5M left a modest 10% surplus.

Mission

TO PROMOTE & REPRESENT THE BIOTECHOLOGY INDUSTRY

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $250,000

Program Service Revenue $1,412,460

Investment Income $35,922

Other Revenue $0

TOTAL REVENUE $1,698,382

Expense Breakdown

Grants Paid $0

Salaries & Benefits $783,032

Fundraising Expenses $0

Program Expenses $1,363,380

Other Expenses $747,844

TOTAL EXPENSES $1,530,876

Year-over-Year Comparison

	2025	2024	Change
Revenue	$1,698,382	$1,383,023	+0.2%
Expenses	$1,530,876	$1,301,887	+0.2%
Net Income	$167,506	$81,136	+1.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✓ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

222

Independent Members

222

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$321,300

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JENNIFER A HAWKS BLAND	CEO	40.00	Officer	$321,300	$0	$321,300
RANA AL-HALLAQ	VICE CHAIR	N/A	Director	$0	$0	$0
HANS CHRISTINGER	CHAIR	N/A	Director	$0	$0	$0
ANTHONY JOHNSON	SECRETARY	N/A	Director	$0	$0	$0
BOB VAN NOSTRAND	TREASURER	N/A	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$1,698,382	$1,530,876	$1,460,770	$167,506
2024	$1,383,023	$1,301,887	$1,311,295	$81,136
2023	$1,372,461	$1,104,989	$1,190,856	$267,472
2022	$1,043,331	$920,485	$944,644	$122,846
2021	$910,681	$777,498	$778,665	$133,183
2020	$862,407	$818,995	$583,396	$43,412
2019	$1,224,465	$891,621	$605,014	$332,844
2018	$977,427	$1,033,473	$296,478	$-56,046

NEW YORK BIOTECHNOLOGY ASSOCIATION INC